These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 22147081

  • 1. GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells.
    Vivacqua A, Romeo E, De Marco P, De Francesco EM, Abonante S, Maggiolini M.
    Breast Cancer Res Treat; 2012 Jun; 133(3):1025-35. PubMed ID: 22147081
    [Abstract] [Full Text] [Related]

  • 2. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.
    Vivacqua A, Bonofiglio D, Recchia AG, Musti AM, Picard D, Andò S, Maggiolini M.
    Mol Endocrinol; 2006 Mar; 20(3):631-46. PubMed ID: 16239258
    [Abstract] [Full Text] [Related]

  • 3. Tamoxifen has a proliferative effect in endometrial carcinoma mediated via the GPER/EGFR/ERK/cyclin D1 pathway: A retrospective study and an in vitro study.
    Zhang L, Li Y, Lan L, Liu R, Wu Y, Qu Q, Wen K.
    Mol Cell Endocrinol; 2016 Dec 05; 437():51-61. PubMed ID: 27519631
    [Abstract] [Full Text] [Related]

  • 4. AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs).
    Cirillo F, Lappano R, Bruno L, Rizzuti B, Grande F, Guzzi R, Briguori S, Miglietta AM, Nakajima M, Di Martino MT, Maggiolini M.
    J Exp Clin Cancer Res; 2019 Aug 01; 38(1):335. PubMed ID: 31370872
    [Abstract] [Full Text] [Related]

  • 5. Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts.
    Madeo A, Maggiolini M.
    Cancer Res; 2010 Jul 15; 70(14):6036-46. PubMed ID: 20551055
    [Abstract] [Full Text] [Related]

  • 6. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
    Santolla MF, Avino S, Pellegrino M, De Francesco EM, De Marco P, Lappano R, Vivacqua A, Cirillo F, Rigiracciolo DC, Scarpelli A, Abonante S, Maggiolini M.
    Cell Death Dis; 2015 Jul 30; 6(7):e1834. PubMed ID: 26225773
    [Abstract] [Full Text] [Related]

  • 7. GPER Mediates Non-Genomic Effects of Estrogen.
    Pupo M, Maggiolini M, Musti AM.
    Methods Mol Biol; 2016 Jul 30; 1366():471-488. PubMed ID: 26585158
    [Abstract] [Full Text] [Related]

  • 8. GPER activates Notch signaling in breast cancer cells and cancer-associated fibroblasts (CAFs).
    Pupo M, Pisano A, Abonante S, Maggiolini M, Musti AM.
    Int J Biochem Cell Biol; 2014 Jan 30; 46():56-67. PubMed ID: 24275097
    [Abstract] [Full Text] [Related]

  • 9. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs).
    De Francesco EM, Lappano R, Santolla MF, Marsico S, Caruso A, Maggiolini M.
    Breast Cancer Res; 2013 Jan 30; 15(4):R64. PubMed ID: 23947803
    [Abstract] [Full Text] [Related]

  • 10. Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1.
    Li Y, Birnbaumer L, Teng CT.
    Mol Endocrinol; 2010 May 30; 24(5):969-80. PubMed ID: 20211987
    [Abstract] [Full Text] [Related]

  • 11. MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells.
    Lappano R, Santolla MF, Pupo M, Sinicropi MS, Caruso A, Rosano C, Maggiolini M.
    Breast Cancer Res; 2012 Jan 17; 14(1):R12. PubMed ID: 22251451
    [Abstract] [Full Text] [Related]

  • 12. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
    Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, Carpino A, Oprea TI, Prossnitz ER, Musti AM, Andò S, Maggiolini M.
    Cancer Res; 2007 Feb 15; 67(4):1859-66. PubMed ID: 17308128
    [Abstract] [Full Text] [Related]

  • 13. 17β-estradiol-induced growth of triple-negative breast cancer cells is prevented by the reduction of GPER expression after treatment with gefitinib.
    Girgert R, Emons G, Gründker C.
    Oncol Rep; 2017 Feb 15; 37(2):1212-1218. PubMed ID: 27959426
    [Abstract] [Full Text] [Related]

  • 14. Insulin-like growth factor-I regulates GPER expression and function in cancer cells.
    De Marco P, Bartella V, Vivacqua A, Lappano R, Santolla MF, Morcavallo A, Pezzi V, Belfiore A, Maggiolini M.
    Oncogene; 2013 Feb 07; 32(6):678-88. PubMed ID: 22430216
    [Abstract] [Full Text] [Related]

  • 15. Estradiol and tamoxifen induce cell migration through GPR30 and activation of focal adhesion kinase (FAK) in endometrial cancers with low or without nuclear estrogen receptor α (ERα).
    Tsai CL, Wu HM, Lin CY, Lin YJ, Chao A, Wang TH, Hsueh S, Lai CH, Wang HS.
    PLoS One; 2013 Feb 07; 8(9):e72999. PubMed ID: 24039841
    [Abstract] [Full Text] [Related]

  • 16. Two novel GPER agonists induce gene expression changes and growth effects in cancer cells.
    Lappano R, Rosano C, Santolla MF, Pupo M, De Francesco EM, De Marco P, Ponassi M, Spallarossa A, Ranise A, Maggiolini M.
    Curr Cancer Drug Targets; 2012 Jun 07; 12(5):531-42. PubMed ID: 22414008
    [Abstract] [Full Text] [Related]

  • 17. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
    Yuan J, Liu M, Yang L, Tu G, Zhu Q, Chen M, Cheng H, Luo H, Fu W, Li Z, Yang G.
    Breast Cancer Res; 2015 May 21; 17(1):69. PubMed ID: 25990368
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-424 suppresses estradiol-induced cell proliferation via targeting GPER in endometrial cancer cells.
    Zhang H, Wang X, Chen Z, Wang W.
    Cell Mol Biol (Noisy-le-grand); 2015 Nov 30; 61(7):96-101. PubMed ID: 26638889
    [Abstract] [Full Text] [Related]

  • 19. Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth.
    Catalano S, Giordano C, Panza S, Chemi F, Bonofiglio D, Lanzino M, Rizza P, Romeo F, Fuqua SA, Maggiolini M, Andò S, Barone I.
    Breast Cancer Res Treat; 2014 Jul 30; 146(2):273-85. PubMed ID: 24928526
    [Abstract] [Full Text] [Related]

  • 20. Estrogenic gper signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (cafs).
    Vivacqua A, De Marco P, Santolla MF, Cirillo F, Pellegrino M, Panno ML, Abonante S, Maggiolini M.
    Oncotarget; 2015 Jun 30; 6(18):16573-87. PubMed ID: 26030000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.